HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 6,625-6,636 of 27,277
Other study type icon
CompletedACTRN12617000354381

A multi-nutrient intervention for pregnant women experiencing symptoms of depression and anxiety.

Official study title

An investigation examining the efficacy and safety of a multi-nutrient intervention on symptoms of antenatal depression and anxiety in pregnant women who are symptomatic: A double blind, randomized, controlled trial

This study has finished and is no longer accepting participants.

In New Zealand
Depression, AnxietyInterventional studyAges 16+
Countries
New Zealand
Sponsor
Professor Julia Rucklidge
Drug study icon
CompletedNCT04714359

A Multi-Site Extension Study of MDMA-Assisted Psychotherapy for PTSD

Official study title

A Multi-Site Open-Label Safety Extension Study of Manualized MDMA-Assisted Psychotherapy for the Treatment of Participants With Posttraumatic Stress Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Los Angeles
PTSDMedication studyAges 18+
Countries
United States, Canada, Israel
Sponsor
Resilient Pharmaceuticals
Behavioral study icon
CompletedNCT03537014

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

Official study title

A Randomized, Double-Blind, Placebo-Controlled, Multi-Site Phase 3 Study of the Efficacy and Safety of Manualized MDMA-Assisted Psychotherapy for the Treatment of Severe Posttraumatic Stress Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including North Hollywood
PTSDMedication studyAges 18+
Countries
United States, Canada, Israel
Sponsor
Resilient Pharmaceuticals
Behavioral study icon
CompletedNCT04077437

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)

Official study title

A Randomized, Double-Blind, Placebo-Controlled, Multi-Site Phase 3 Study of the Efficacy and Safety of Manualized MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder of Moderate or Greater Severity

This study has finished and is no longer accepting participants.

Multiple locations, including Los Angeles
PTSDMedication studyAges 18+
Countries
United States, Israel
Sponsor
Resilient Pharmaceuticals
Drug study icon
CompletedNCT00606229

Safety and Efficacy of Long-term Administration of Aripiprazole for Bipolarity

What is this study about?

This study evaluated the safety and effectiveness of Aripiprazole for people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Chugoku Region
BipolarityMedication studyAges 18–65
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd. (Pharmaceutical company)
Drug study icon
CompletedNCT02220712

A Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in people with Schizophrenia

What is this study about?

This study evaluated the safety of OPC-14597 IMD for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Chugoku Region
SchizophreniaMedication studyAges 18–64
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd. (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.